
Sanofi
Job Title:2027 Spring Co-op Quantitative Pharmacology
Grade:Co-op
Location:Morristown, NJ
Duration:6 months
About the Job
Looking to launch your career at the cutting edge of healthcare? Join Sanofi for a chance to develop with mentoring and guidance from inspirational leaders while helping to make an impact on the lives of countless people worldwide. We are seeking a highly motivated Spring Co-op to join our Quantitative Pharmacology team.
The Quantitative Pharmacology (QP) department is an integral part of the Translational Medicine Unit within Sanofi. We leverage model-informed drug development (MIDD), including population pharmacokinetic (PK) and pharmacodynamic (PD) approaches, to support optimal decision-making and accelerate programs across the full drug development continuum, from early discovery through late-stage clinical development. In addition, we actively explore the integration of artificial intelligence and machine learning (AI/ML) approaches to complement traditional pharmacometrics methods and enhance >
Better is out there. Better medications, better outcomes, better science. But progress doesn’t happen without people – people from different backgrounds, in different locations, doing different roles, all united by one thing: a desire to make miracles happen. So, let’s be those people.
Sanofi US endeavours to make our career center accessible to any and all users. If you are experiencing difficulty and need assistance applying online, please call 1-866-SANOFI2 (1-866-726-6342) or click here
US and Puerto Rico Residents Only
Sanofi Inc. and its U.S. affiliates are Equal Opportunity employers committed to a culturally inclusive workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.